Literature DB >> 10363676

Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin.

M Marchetti1, F Superti, M G Ammendolia, P Rossi, P Valenti, L Seganti.   

Abstract

In this study we investigated the inhibitory activity of different milk proteins on poliovirus infection in Vero cells. Proteins analyzed were mucin, alpha-lactalbumin, beta-lactoglobulin, and bovine and human lactoferrin. Viral cytopathic effect was not prevented by mucin, alpha-lactalbumin or beta-lactoglobulin, whereas the lactoferrins tested were able to inhibit the replication of poliovirus in a dose-dependent manner. Further experiments were carried out in which apo- and native lactoferrin or lactoferrin fully saturated with ferric, manganese or zinc ions were added to the cells during different phases of viral infection. Results obtained demonstrated that all lactoferrins were able to prevent viral replication when present during the entire cycle of poliovirus infection or during the viral adsorption step. Only zinc lactoferrin strongly inhibited viral infection when incubated with the cells after the viral attachment, being the inhibition directly correlated with the degree of zinc saturation. Our results demonstrated that all lactoferrins interfered with an early phase of poliovirus infection; zinc lactoferrin was the sole compound capable of inhibiting a phase of infection subsequent to virus internalization into the host cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363676     DOI: 10.1007/s004300050093

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

1.  Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides.

Authors:  Agostina Pietrantoni; Assunta Maria Di Biase; Antonella Tinari; Magda Marchetti; Piera Valenti; Lucilla Seganti; Fabiana Superti
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.

Authors:  Songtao Li; Haibo Zhou; Guirong Huang; Ning Liu
Journal:  Med Microbiol Immunol       Date:  2008-09-23       Impact factor: 3.402

Review 3.  Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin.

Authors:  Romina Mancinelli; Luigi Rosa; Antimo Cutone; Maria Stefania Lepanto; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Piera Valenti
Journal:  Molecules       Date:  2020-04-24       Impact factor: 4.411

Review 4.  Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.

Authors:  Elena Campione; Terenzio Cosio; Luigi Rosa; Caterina Lanna; Stefano Di Girolamo; Roberta Gaziano; Piera Valenti; Luca Bianchi
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

Review 5.  Antiviral properties of lactoferrin--a natural immunity molecule.

Authors:  Francesca Berlutti; Fabrizio Pantanella; Tiziana Natalizi; Alessandra Frioni; Rosalba Paesano; Antonella Polimeni; Piera Valenti
Journal:  Molecules       Date:  2011-08-16       Impact factor: 4.411

Review 6.  Lactoferrin a multiple bioactive protein: an overview.

Authors:  Isui Abril García-Montoya; Tania Siqueiros Cendón; Sigifredo Arévalo-Gallegos; Quintín Rascón-Cruz
Journal:  Biochim Biophys Acta       Date:  2011-06-25

7.  Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.

Authors:  Esmail M El-Fakharany; Lourdes Sánchez; Hussein A Al-Mehdar; Elrashdy M Redwan
Journal:  Virol J       Date:  2013-06-19       Impact factor: 4.099

8.  Bovine Lactoferrin Inhibits Dengue Virus Infectivity by Interacting with Heparan Sulfate, Low-Density Lipoprotein Receptor, and DC-SIGN.

Authors:  Jo-Mei Chen; Yi-Chin Fan; Jen-Wei Lin; Yi-Ying Chen; Wei-Li Hsu; Shyan-Song Chiou
Journal:  Int J Mol Sci       Date:  2017-09-12       Impact factor: 5.923

Review 9.  Human Antimicrobial Peptides as Therapeutics for Viral Infections.

Authors:  Aslaa Ahmed; Gavriella Siman-Tov; Grant Hall; Nishank Bhalla; Aarthi Narayanan
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048

10.  The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification.

Authors:  Anna Oevermann; Monika Engels; Ursula Thomas; Antonio Pellegrini
Journal:  Antiviral Res       Date:  2003-06       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.